Long Focus Capital Management, LLC Caribou Biosciences, Inc. Transaction History

Long Focus Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	BUY	$4.3 - $7.78 $69,875 - $126,425	16,250 Added 33.33%	65,000 $345,000
Q1 2023 May 12, 2023	SELL	$4.3 - $7.78 $69,875 - $126,425	-16,250 Reduced 25.0%	48,750 $258,000
Q3 2022 Nov 14, 2022	SELL	$5.34 - $12.79 $80,100 - $191,850	-15,000 Reduced 18.75%	65,000 $686,000
Q2 2022 Aug 12, 2022	BUY	$5.1 - $9.74 $408,000 - $779,200	80,000 New	80,000 $434,000

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $110M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of Long Focus Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Long Focus Capital Management, LLC with notifications on news.